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The risk of specific cancers increases in patients
with metabolic dysfunction, including obesity and
diabetes. Here, we use Drosophila as a model to
explore the effects of diet on tumor progression.
Feeding Drosophila a diet high in carbohydrates
was previously demonstrated to direct metabolic
dysfunction, including hyperglycemia, hyperinsuli-
nemia, and insulin resistance. We demonstrate that
high dietary sugar also converts Ras/Src-trans-
formed tissue from localized growths to aggressive
tumors with emergent metastases. Whereas most
tissues displayed insulin resistance, Ras/Src tumors
retained insulin pathway sensitivity, increased the
ability to import glucose, and resisted apoptosis.
High dietary sugar increased canonical Wingless/
Wnt pathway activity, which upregulated insulin
receptor gene expression to promote insulin sensi-
tivity. The result is a feed-forward circuit that ampli-
fied diet-mediated malignant phenotypes within
Ras/Src-transformed tumors. By targeting multiple
steps in this circuit with rationally applied drug
combinations, we demonstrate the potential of
combinatorial drug intervention to treat diet-
enhanced malignant tumors.INTRODUCTION
The prevalence of metabolism-related diseases, including type 2
diabetes and obesity, has been increasing worldwide. Metabolic
disease impacts body homeostasis, leading to a constellation of
symptoms, including cardiovascular disease, blindness, neurop-
athy, and nephropathy. Recently, the American Diabetes Associ-
ation and American Cancer Society jointly published a
consensus report emphasizing accumulating evidence that pa-
tients with diabetes also show elevated risks of specific cancer
types (Giovannucci et al., 2010). Epidemiological studies have
provided strong evidence for the association between cancer664 Cell 154, 664–675, August 1, 2013 ª2013 Elsevier Inc.and metabolic diseases, including diabetes and obesity (Barone
et al., 2008; Calle et al., 2003; Coughlin et al., 2004; Inoue et al.,
2006); patients with metabolic dysfunction have both a higher
incidence of specific tumor types and a higher overall cancer-
related mortality. For example, obese patients with progester-
one-receptor-negative breast cancer had a higher risk of lymph
node metastasis, suggesting that metabolic dysfunction can
promote tumor aggressiveness (Maehle et al., 2004). The in-
crease in metabolic diseases worldwide highlights metabolic
dysfunction as an increasing issue in cancer progression. How-
ever, the mechanisms by which metabolic dysfunction contrib-
utes to cancer progression remain poorly understood.
Obesity and type 2 diabetes are typically associated with
chronic hyperinsulinemia; levels of insulin in the blood rise to
compensate for insulin resistance. Increased circulating insulin
levels are in turn a risk factor for the development of hepatocel-
lular carcinoma and colorectal cancer (Donadon et al., 2009;
Kaaks et al., 2000). Together with the well-documented mito-
genic effects of insulin (Ish-Shalom et al., 1997), this evidence
suggests a role for hyperinsulinemia as a promoter of enhanced
tumorigenesis in obese and diabetic patients. However, the
development of insulin resistance in metabolism-related dis-
eases raises a key question: how do tumors overcome insulin
resistance to take advantage of increasing insulin levels? Here,
we utilize Drosophila to explore the effects of high dietary sugar
on tumor progression in vivo.
Feeding Drosophila a diet supplemented to 1.0 M sucrose led
to insulin resistance, hyperglycemia, increased insulin levels
(hyperinsulinemia), and accumulation of fat, phenocopying
important aspects of type 2 diabetes (Musselman et al., 2011).
We used this model to explore the effects of high dietary sugar
on tumor progression in vivo. On a normal diet, Csk/Src-depen-
dent tumors were eliminated from the epithelium either alone or
when paired with an oncogenic Ras isoform. In contrast,
elevated dietary sugar strongly synergized with Ras/Src to
generate large tumors associated with aggressive metastasis-
like behavior. Using this model system, we investigated whether
increased insulin levels underlie induction of malignant tumors.
Importantly, Ras/Src-activated tumors remained sensitive to in-
sulin in dietary conditions that promoted insulin resistance in sur-
rounding tissues. We demonstrate that increased insulin/PI3K
signaling in turn prevents apoptosis and promotes canonical
Wingless/Wnt mitogenic signaling in Ras/Src tumors. Our results
provide functional data that, in the face of high dietary sugar,
Ras/Src-activated cells escape insulin resistance to exhibit
enhanced growth that is dependent on Wingless/Wnt mitogenic
signaling.
RESULTS
High Dietary Sucrose Enhanced Tumor Growth
Feeding Drosophila a standard diet supplemented to 1.0 M
sucrose (high dietary sucrose or ‘‘HDS’’) led tometabolic defects
reminiscent of specific aspects of type 2 diabetes, including
insulin resistance, hyperglycemia, elevated Drosophila insulin-
like peptide (DILP) levels, and accumulation of body fat (Mussel-
man et al., 2011). To explore the link betweenmetabolic dysfunc-
tion and tumor progression, we compared Drosophila cancer
models fed HDS to those fed a control (0.15 M sucrose) diet.
Combined elevation of Ras and Src pathway activities is a com-
mon motif in multiple cancer types, including breast, colorectal,
and pancreatic cancer (Ishizawar and Parsons, 2004; Morton
et al., 2010). Experimentally, oncogenic K-Ras plus Src isoforms
cooperate to accelerate the onset of pancreatic ductal adeno-
carcinoma in mice models, and Ras plus Src act together to pro-
mote tumorigenesis inDrosophila (Shields et al., 2011; Vidal et al.,
2007). We further developed this model by pairing transgenes
that express oncogenic ras1G12V in the eyewith the genotypically
null cskQ156Stop allele of Csk, a primary negative regulator of
Src kinase. Clones were labeled with GFP to visualize tumor pro-
gression. In control eyes, GFP expression was comparable in
control diet versus HDS, indicating that high-sucrose feeding
did not alter transgene expression levels (Figures 1A and 1B).
Genotypically csk null clones alone were rarely obtained when
fed either a control diet or HDS (Figures 1C and 1D) due to Src-
mediated apoptosis (Vidal et al., 2006). Also, as previously
reported (Pagliarini and Xu, 2003), targeting ras1G12V to the eye
resulted in isolated benign tumors that in turn led to lethality as
pupae (Figure 1E). ras1G12V animals fed HDS exhibited at most
a mild increase in growth within the eye field (Figure 1F). Eyes
with elevated Ras plus Src activity (ras1G12V;csk/) raised on
a control diet displayed fewer and smaller GFP-positive clones
compared to ras1G12V-expressing clones alone (Figures 1E and
1G), indicating that ras1G12V expression cannot overcome elim-
ination of csk mutant cells.
By striking contrast, clones displayed strongly increased pro-
liferation in 96.5% of ras1G12V;csk/ larvae fed HDS. The result
was striking overgrowth and a significantly enlarged GFP-posi-
tive eye field that dominated the head region (Figures 1H and
1I). This overgrowth had consequences on animal viability; a ma-
jority (77.5%) of ras1G12V;csk/ animals fed HDS failed to initiate
pupariation, instead dying as larvae with multiple secondary tu-
mors (Figure S1A available online). Together, these results indi-
cate that the metabolic status of the animals, as influenced by
diet, strongly affects the outcome of Ras/Src-mediated tumori-
genesis in the eye epithelium.
HDS feeding led to an 4 day delay in completion of larval
development (Musselman et al., 2011) (Figure S1B); therefore,
phenotypes were compared between developmental-stage-
matched animals fed HDS versus a control diet (late third-instarlarvae). To rule out the possibility that enhanced tumor growth in
HDS-fed animals was due to their older chronological age, we
also analyzed progressive clone sizes in chronological-age-
matched animals (Figures 1K–1S). At day 9 after egg laying
(AEL), larval eye tissue was significantly smaller in HDS-fed ani-
mals than in age-matched controls (12.9%; Figures 1M0, 1N0,
and S1C), but the percentage area occupied by GFP-positive
clones was already significantly larger (13.5% in control diet
and 42.8% in HDS; Figures 1M0, 1N0, and 1S). This difference
widened over time; control clones decreased from 35.2% (day
7 AEL) to 13.5% (day 9 AEL) of total area while HDS clones pro-
gressively increased, reaching 58.9% at day 11 AEL and 93.7%
at day 13 AEL (Figures 1K–1S). These analyses further support a
role for HDS in enhancing growth of ras1G12V;csk/ tumors.
HDS, but Not High Fat, Induced Cancer Phenotypes
Diets containing 2.0Mglucoseenhanced ras1G12V;csk/growth
at a level similar to diets containing 1.0 M sucrose (Figures 1H
and S2A). Other diets, including pure banana, that have similar
carbohydrate content yielded similar tumor enhancement
(Figure S2B), further emphasizing the specific role of high dietary
carbohydrates. By contrast, ras1G12V;csk/ tumors failed to
show enhanced tumor growth in a calorie-matched high-fat
diet (Figure S2C), indicating that high levels of dietary carbo-
hydrates, but not high total caloric levels, are responsible for
the enhanced cancer phenotype. This is consistent with
observations that a high-carbohydrate diet in general leads to
metabolic defects in Drosophila not observed with calorie-
matched high-fat or high-protein diets (Musselman et al., 2011).
HDS Promoted Aspects of Invasive Migration and
Distant Secondary Tumors
Basement membrane degradation by matrix metalloproteases
(MMPs) is a key early step in the initiation of cell spreading and
metastasis (Deryugina and Quigley, 2006). Eye epithelia from
ras1G12V;csk/ animals fed a control diet displayed an intact
basement membrane as assessed by Laminin A (Figure 2A).
HDS feeding led to broad loss of Laminin A; loss was already
evident at day 9 AEL (Figure 2B and S2D). However,
ras1G12V;csk/-mediated upregulation of MMP1 expression
was independent of dietary sugar (Figures 2E and 2F). Our
data suggest that HDS enhances breakdown of the basement
membrane to facilitate spreading and metastasis-like behavior
of transformed cells, at least in part bymechanisms independent
of MMP1 expression levels.
Larvae fed HDS consistently (93.0%) displayed GFP-labeled
ras1G12V;csk/ cells scattered throughout their hemolymph, a
blood analog (Figures 2I–2K and 2S). A total of 19.1% of these
larvae also developed secondary rasG12V;csk/ tumors distant
from the eye field that continued to proliferate (Figures 2L, 2P,
and 2S); secondary tumors were rarely (0.8%) observed in ani-
mals fed control food (Figure 2S). Whereas the percentage of
animals with loss of Laminin in the eye tissue correlated with
the percentage of animals with GFP-positive cells in the hemo-
lymph, readily scorable secondary tumors were found in only a
subset (19.1%) of the animals fed HDS (Figure 2S).
Combining ras1G12V with a weaker csk allele, cskj1D8
(ras1G12V;cskhypo/hypo), led to a reduced penetrance of secondaryCell 154, 664–675, August 1, 2013 ª2013 Elsevier Inc. 665
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Figure 1. HDS Diverts Ras/Src-Activated Cells into Aggressive Tumors
(A–I) Developmental-stage-matched third-instar larvae fed a control diet or HDS. (A andB) lacZ control in the control diet (day 7 AEL) andHDS (day 11 AEL). (C and
D) csk/ in control diet (day 7 AEL) and HDS (day 11 AEL). (E and F) ras1G12V in control diet (day 8 AEL) and HDS (day 12 AEL). (G–I) ras1G12V;csk/ in control diet
(day 9 AEL) and HDS (day 13 AEL). The latter demonstrated secondary tumors in a subset of animals (arrowhead in I).
(A0–H0) Matching dissected eye epithelial tissue stained with DAPI (red).
(J) Quantitation of the observedphenotypes. The blue bar represents eye discswithout overgrowth (e.g., Figure 1G), the red bar is eye discswith tumor overgrowth
and overall enlarged tissue size (e.g., Figure 1H), and the green bar is animals with secondary tumors (e.g., Figure 1I). Results are shown as mean ± SEM.
(K–R) Chronological-age-matched larvae fed a control diet or HDS. ras1G12V;csk/ animals shown at day 7 AEL (K and L), day 9 AEL (M andN), day 11 AEL (O and
P), and day 13 AEL (Q and R).
(K0, M0, N0, P0, and R0 ) Matching dissected eye epithelial tissue stained with DAPI (red).
(S) Quantitation of the percentage of GFP-positive clone area percentage relative to total eye tissue area. Results are shown as mean ± SEM of individual eye
discs. *Not assessed due to early (small discs, day 7) or late (everted pupal discs) stages.
See also Figure S1.
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Figure 2. Ras/Src Tumors in HDS Spread
intoHemolymph andColonize Near Trachea
to Form Secondary Tumors
(A–D) Laminin A staining (red) of developmental-
stage-matched ras1G12V;csk/ or inRCA,ras1G12V;
csk/ eye discs raised on the indicated diets.
(E–H) MMP1 staining (red) of developmental-
stage-matched ras1G12V;csk/ or inRCA,
ras1G12V;csk/ eye discs raised on the indicated
diets.
(I–K) Ventral view of ras1G12V;csk/ animals
raised on HDS. (I) Zoom up of the inset is shown in
(J), and the extracted hemolymph on mineral oil is
shown in (K).
(L–O) ras1G12V;csk/ animals raised on HDS with
growing secondary tumor (arrow). GFP (M), bright
field (BF) (N), and merged image (O) of the
dissected secondary tumor is shown.
(P) Phospho-histone H3 staining (p-HH3; red) of
ras1G12V;csk/ secondary tumor.
(Q) Chitin-binding probe staining (red) of
ras1G12V;csk/ secondary tumor attached to tra-
chea. Zoom up of the inset is shown in the middle.
(R) Branchless staining (bnl; red) of a
ras1G12V;csk/ secondary tumor attached to tra-
chea.
(S) Phenotype quantitation. Blue bar represents
the percentage of animals with loss of Laminin
staining in the eye discs. Red bar is the percentage
of animals with GFP-positive cells in the hemo-
lymph. Green bar is the percentage of animals
with secondary tumors. Results are shown as
mean ± SEM.
See also Figure S2.tumors (Figures S2E, S2F, S2F0, and S2G), suggesting that levels
of Src activity play a primary role in distant Ras/Src tumor forma-
tion. We also examined scribbled, which encodes a protein
required to maintain apical/basal cell polarity (Bilder and Perri-
mon, 2000). As previously reported (Pagliarini and Xu, 2003;
Brumby and Richardson, 2003), targeting ras1G12V;scrib/ to
the eye led to substantial overgrowth; however, we did not
observe secondary tumors in these animals when fed either a
control diet or HDS (Figures S2H–S2J). These results indicate a
specific relationship between Ras and Csk/Src activities that,
when combined with HDS, synergize to produce secondary tu-
mors. The data also indicate that tumor overgrowth and second-
ary tumor formation are separable processes and, similar to
mammals (Mehlen and Puisieux, 2006), only a small subset of
circulating cells successfully seed a secondary tumor.
Larger secondary ras1G12V;csk/ tumorswere typically tightly
associatedwith the tracheal system, a tubular network that trans-
ports oxygen (Figures 2L–2O). A Chitin-binding probe (Devine
et al., 2005) indicated that secondary tumors enwrapped tracheal
branches (Figure 2Q). Interestingly, Chitin was abnormallyCell 154, 664–67deposited within these tumor-imbedded
trachea (Figure 2Q), suggesting either
tracheal alteration or de novo branching.
Consistent, but not proving the latter
view, secondary ras1G12V;csk/ tumors
expressed Branchless (Figure 2R), a fly fibroblast growth factor
(FGF) ortholog capable of promoting de novo trachea branching
(Sutherland et al., 1996). Together, these results indicate that
HDS enhances or establishes multiple aspects of tumorigenesis
in the presence of activated Ras/Src, including proliferation,
a block in apoptosis, invasive migration, and establishment of
secondary tumors distant from the primary tumor.
The PI3K Pathway Mediates Diet-Induced
Tumorigenesis
Genetically reducing PI3K activity through a hypomorphic allele
of akt (ras1G12V;csk/,akthypo/hypo; Figure 3B) or through feeding
of the PI3K inhibitor wortmannin (Figure S3) led to strongly
reduced tumor cell survival in the presence of HDS. The Tor-
class inhibitor rapamycin displayed a similar reduction in tumor
tissue (Figure S3); in addition, animals were significantly smaller
with an extended third-instar larval stage, as previously reported
(Zhang et al., 2000). Conversely, coexpressing the constitutively
active insulin receptor isoform inRCA (inRCA,ras1G12V;csk/) in
animals fed a control diet prevented elimination of clones from5, August 1, 2013 ª2013 Elsevier Inc. 667
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Figure 3. Ras/Src-Activated Cells Evade Insulin Resistance
(A and B) Developmental-stage-matched animals raised on HDS with the genotype, (A) ras1G12V;csk/, (B) ras1G12V;csk/,akthypo/hypo.
(C and D) Developmental-stage-matched animals raised on control diet with the genotype, (C) ras1G12V;csk/, (D) inRCA,ras1G12V;csk/. Note that
inRCA,ras1G12V;csk/ animals fed a control diet led to overgrowth, but not secondary tumor formation.
(E) inRCA,ras1G12V;csk/ animals fed HDS.
(A0–E0 ) Matching dissected eye epithelial tissue stained with DAPI (red).
(F) Quantitation of the observed phenotypes. The three color bars are explained in the legend of Figure 1J. Results are shown as mean ± SEM.
(G and H) Dissected eye tissue of lacZ (G) or ras1G12V;csk/ (H) animals fed a control diet or HDS were treated with or without Insulin, and total Akt, phospho-Akt
(p-Akt), and Syntaxin (Syt) levels were examined by immunoblotting. The results of immunoblots were quantitated using ImageJ software and p-Akt/Syt values
relative to subject without Insulin stimulation were determined. Results are shown as mean ± SEM.
(legend continued on next page)
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the epithelia. The result was tumor overgrowth in which 91.0% of
larvae displayed an enlarged eye disc phenotype (Figures 3D
and 3F). inRCA,ras1G12V;csk/ animals did not exhibit any
further increase in primary tumor size when raised on HDS (Fig-
ure 3E), nor did they exhibit enhanced tumors when compared to
ras1G12V;csk/ in HDS (compare Figures 1J and 3F). We
conclude that components of the Insulin/PI3K pathway are
required autonomously within the ras1G12V;csk/-transformed
cells for enhancement by HDS.
Of note, Insulin/PI3K signaling did not mediate all of the effects
of HDS. While the triple combination inRCA,ras1G12V;csk/ fed a
control diet exhibited strongly enhanced expansion of tumors
within the eye field, overgrowth was not accompanied bymetas-
tasis-like behavior or secondary tumor formation. Further,
though elevatedMMP1 expression was observed, the basement
membrane was still retained (Figures 2C and 2G). This result
again emphasizes that tumor overgrowth and metastasis are
separable processes.
Ras/Src-Activated Cells Remain Sensitive to Insulin and
Glucose
Our results suggest that insulin signaling is required to mediate
HDS-enhanced growth. However, eye epithelial tissue in control
animals raised on HDS exhibited reduced phosphorylated, acti-
vated Akt upon Insulin stimulation, an indication of insulin resis-
tance as previously reported (Figure 3G) (Musselman et al.,
2011). This led us to a central question in tumor metabolism
studies: how does a diet that promotes insulin resistance also
enhance tumors in an Insulin/PI3K-dependent manner?
In contrast to controls, eye tissue within ras1G12V;csk/ ani-
mals fed HDS exhibited an increase in baseline Akt when
compared to control-diet-fed animals (Figure 3H), suggesting
these tissues were in fact not insulin resistant. Consistent with
this view, challenging eye tissue from HDS animals with exoge-
nous Insulin led to a strong increase in phospho-Akt (Figure 3H).
Insulin-stimulated increase in phospho-Akt was observed auton-
omously within the ras1G12V;csk/ clones (Figure 3I). These data
indicate that activating the Ras and Src pathways reversed HDS-
induced insulin resistance, leading to hypersensitive responsive-
ness to Insulin. The result was increased sugar flux; in the
presence or absence of exogenous Insulin, ras1G12V;csk/ ani-
mals raised on HDS displayed a significant increase in glucose
uptake to a level comparable to the triple combination inRCA,
ras1G12V;csk/ (Figures 3J–3N). Reducing akt activity (ras1G12V;
csk/,akthypo/hypo) blocked glucose uptake (Figure 3O). We con-
clude that ras1G12V;csk/cells escapediet-induced insulin resis-
tance to utilize both increased insulin responsiveness and insulin-
pathway-dependent glucose uptake. We next explored the
mechanismsbywhich transformed cells evade insulin resistance.
Tumors Exhibit Aspects of an ‘‘Undead’’ Phenotype
A central hallmark of mammalian cancer is the ability of trans-
formed cells to evade apoptosis. In Drosophila developing eye(I) Dissected eye tissue from ras1G12V;csk/ animals fed HDS were treated with
(J–O) Glucose uptake was examined by uptake of 2-NBDG of the dissected e
ras1G12V;csk/,akthypo/hypo (O) animals fed a control diet or HDS, with or withou
See also Figure S3.and wing epithelia, keeping otherwise apoptotic cells alive
(undead) by blocking effector caspase activity leads to aberrant
tissue overgrowth due to compensatory proliferation of sur-
rounding cells, a process designed to maintain tissue size and
integrity (reviewed in Bergmann and Steller, 2010; Fan and
Bergmann, 2008; Martı´n et al., 2009). We used an antibody
that recognizes the cleaved, active isoform of human caspase-
3, a validated readout for activity of the Drosophila initiator
caspase Dronc (Fan and Bergmann, 2010). We observed broad
Dronc activity in ras1G12V;csk/ clones of animals raised on a
control diet (Figures 4A and S4A). A significant proportion of
these cells were undergoing apoptotic cell death as assessed
by TUNEL staining (Figures 4D and S4A).
In the presence of HDS, ras1G12V;csk/ clones also exhibited
broad cytosolic Dronc activity (Figures 4B and S4A). However,
these clones were almost completely negative for apoptotic
cell death as assessed by TUNEL and DAPI analysis (Figures
4E and S4A; data not shown); a few cells outside of the clone
region were TUNEL positive. Insulin pathway activation alone
was sufficient to mimic this block: inRCA,ras1G12V;csk/ animals
fed a control diet retained Dronc caspase activity but, again,
were resistant to apoptotic cell death as assessed by TUNEL
(Figures 4C, 4F, and S4A). One candidate to block apoptosis in
transformed cells is the caspase inhibitor Drosophila inhibitor
of apoptosis protein 1 (Diap1), which inhibits caspases down-
stream of Dronc (Ditzel et al., 2008). diap1 gene expression
and Diap1 protein levels were strongly increased in the ras1G12V;
csk/ clones of animals raised in HDS compared to animals fed
a control diet (Figures 4G–4I, S4B, and S4C). The triple combina-
tion inRCA,ras1G12V;csk/ was sufficient to elevate diap1
expression and Diap1 protein levels in animals fed a control
diet, whereas reduced akt activity (ras1G12V;csk/,akthypo/hypo)
failed to elevate Diap1 in HDS animals (Figures 4J, S4D, and
S4E). These results indicate that elevation of insulin pathway
signaling through HDS leads to elevated Diap1 and a block in
apoptotic cell death downstream of cleaved, activated Dronc.
Interestingly, secondary tumors retained diap1 expression but
lost Dronc activity (Figures S4G and S4H).
Increased Wingless/Wnt Signaling Mediates Diet-
Induced Tumorigenesis
Previous work in Drosophila compensatory proliferation found
that undead cells also elevate expression of the Wnt ortholog
Wingless (Wg); this mitogenic signal in turn directs local hyper-
plasia (Pe´rez-Garijo et al., 2009). In ras1G12V;csk/ eye clones,
we detected low levels of Wg protein within the clones in animals
fed a control diet (Figure 4K). Notably, Wg protein levels were
strongly upregulated in animals fed HDS (Figures 4L and 4M).
Reducing akt activity (ras1G12V;csk/,akthypo/hypo) prevented
this elevation (Figure S4F), whereas the triple combination
inRCA,ras1G12V;csk/ displayed increased Wg levels in animals
fed a control diet (Figure 4N). Activation of InR alone was not suf-
ficient to elevate Wg levels (Figure S5A). We conclude thatInsulin and immunostained with anti-phospho-Akt (p-Akt) antibody.
ye tissue from inRCA,ras1G12V;csk/ (J), ras1G12V;csk/ (K–M), lacZ (N), or
t Insulin stimulation.
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Figure 4. Ras/Src Tumors Are Resistant to Apoptosis in a High-Sucrose Diet
(A–C) Cleaved caspase-3 staining (red) of ras1G12V;csk/ (A and B) or inRCA,ras1G12V;csk/ (C) eye discs raised on the indicated diets.
(D–F) A TUNEL assay (red) was used to label apoptotic cell death of ras1G12V;csk/ (D and E) or inRCA,ras1G12V;csk/ (F) eye discs raised on the indicated diets.
(G–J) b-galactosidase (b-gal) staining (red) of eye discs from ras1G12V;csk/,diap1-lacZ animals on a control diet (G), HDS at day 13 AEL (H), HDS at day 11 AEL
(I), and inRCA,ras1G12V;csk/,diap1-lacZ animals on a control diet (J).
(K–N) Wingless (Wg) staining (red) of eye discs from ras1G12V;csk/ animals on a control diet (K), HDS at day 13 AEL (L), HDS at day 11 AEL (M), and
inRCA,ras1G12V;csk/,diap1-lacZ on a control diet (N).
See also Figure S4.
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Figure 5. WgMediates Ras/Src Tumorigen-
esis in HDS
(A–D) Animals raised onHDSwith the genotype, (A)
ras1G12V;csk/, (B) ras1G12V;csk/,wgRNAi, (C)
ras1G12V;csk/,tcfDN, (D) ras1G12V;csk/,bskDN.
(A0–D0) Matching dissected eye epithelial tissue
stained with DAPI (red).
(E and F) Wingless (Wg) staining (red) of
ras1G12V;csk/,bskDN eye discs raised on HDS (E)
and inRCA,ras1G12V;csk/,bskDN eye discs raised
on a control diet (F).
(G) Dissected eye tissue of LacZ control or HA-Wg
animals fed HDS were treated with or without In-
sulin, and total Akt, phospho-Akt (p-Akt), and
Syntaxin (Syt) levels were examined by immuno-
blotting. The results of immunoblots were quan-
titated using ImageJ software. Results are shown
as mean ± SEM.
(H and I) Histogram showing the levels of rpL32,
inR, chico, and lnk mRNAs measured by quanti-
tative RT-PCR. Total RNA was isolated from
LacZ-expressing control eye discs (H) or
ras1G12V;csk/ eye discs (I) raised on a control
diet (black bar) or HDS (white bar) or
ras1G12V;csk/,tcfDN eye discs raised on HDS
(gray bar). Results are shown as mean ± SEM.
Asterisks indicate statistically significant differ-
ence (*p < 0.01; **p < 0.05).
(J) Dissected eye tissue of ras1G12V;csk/ ani-
mals fed a control diet or HDS were treated with or
without Insulin, and phospho-Insulin receptor (p-
InR) and Syntaxin (Syt) levels were examined by
immunoblotting.
(K) Model of diet-mediated tumorigenesis of Ras/
Src-activated cells.
See also Figure S5.combining elevated InR, Ras, and Src activities leads to elevated
Wg expression in discrete tumors.
Elevation of Wg contributed to tumor progression. Reducing
Wg activity (ras1G12V;csk/,wgRNAi) in animals fed HDS led to
strong suppression of tumor growth (Figure 5B). Expression of
a dominant-negative isoform of the downstream pathway
effector Tcf (ras1G12V;csk/,tcfDN) also suppressed tumor
growth (Figure 5C), indicating that canonical Wg signaling is
required for high-sucrose-induced enhancement of tumorigen-
esis. As a result, whereas only 22.5% of ras1G12V;csk/ animals
successfully initiated pupariation when fed HDS, 100% of
ras1G12V;csk/,wgRNAi or ras1G12V;csk/,tcfDN animals suc-
cessfully pupariated when fed HDS (Figures S5B and S5C).
In undead cells, Jnk pathway signaling is required for ectopic
Wg expression (Ryoo et al., 2004). Expressing a dominant-nega-
tive isoform of the Drosophila Jnk ortholog Basket bskDN
(ras1G12V;csk/,bskDN) suppressed tumor growth in HDS (Fig-Cell 154, 664–67ures 5D and S5D) and blocked the eleva-
tion in Wg protein levels (Figure 5E), indi-
cating that Wg upregulation is
downstream of Bsk. Wg was also
blocked in inRCA,ras1G12V;csk/,bskDN
eye clones of animals fed a control diet,
indicating Bsk is in turn downstream ofInR with regard to elevated Wg (Figure 5F). Together, these re-
sults indicate that ras1G12V;csk/ cells achieve an undead sta-
tus through Diap1, which then activates a InR-Jnk-Wg pathway
that promotes cell-autonomous proliferation. We next asked
whether this ability of Wg to mediate key aspects of HDS/insulin
pathway activity within Ras/Src-activated tumors extended to
evasion of insulin resistance.
Canonical Wingless/Wnt Pathway Signaling Promotes
Insulin Sensitivity by Regulating InR Expression
In organ culture experiments from animals fed HDS, chal-
lenging control tissue with exogenous Insulin led to little or no
increase in pathway activity as assessed by phosphorylated
Akt (Figure 5G); we also observed significant downregulation
of inR messenger RNA (mRNA) (Figure 5H), which presumably
at least partially accounts for the tissues’ insulin resistance.
Two other members of the Insulin pathway, Chico/IRS and5, August 1, 2013 ª2013 Elsevier Inc. 671
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Figure 6. Combinatorial Multinode Drug
Treatment for Ras/Src Tumors in HDS
(A–H) ras1G12V;csk/ animals fed HDS containing
(A) 0.05% DMSO, (B) 20 mM acarbose, (C) 25 mM
pyrvinium, (D) 50 mM AD81, (E) 20 mM acarbose plus
25 mM pyrvinium, (F) 20 mM acarbose plus 50 mM
AD81, (G) 25 mM pyrvinium plus 50 mM AD81, or (H)
20 mM acarbose plus 25 mM pyrvinium plus 50 mM
AD81. All phenotypes were assessed at day 17 AEL.
(I) Cell extracts from dissected eye tissue of
ras1G12V;csk/ animals fed HDS supplementedwith
DMSO, AD80, or AD81 were examined by immuno-
blotting.
(J) Percent pupariation of DMSO- or drug-treated
ras1G12V;csk/ animals was determined at day 17
AEL. Results are shown as mean ± SEM.
See also Figure S6.Lnk/SH2B, showed no change in transcript levels (Figure 5H),
suggesting that diet-directed downregulation is specific to
InR. In contrast, tissue expressing Wg responded to exogenous
Insulin by strongly activating pathway signaling (Figure 5G).
This suggests that, in addition to Insulin regulating Wg, Wg reg-
ulates Insulin signaling, potentially through the regulation of inR
expression.
Consistent with this model, inRmRNA levels were significantly
upregulated in ras1G12V;csk/ eye clones in animals fed HDS
(Figure 5I). The result was an increase in phosphorylated,
activated InR that was strongly enhanced when the tissue was
challenged with exogenous Insulin (Figure 5J). Importantly, the
diet-dependent increase in inR mRNA levels was suppressed
by reducing activity of the Wg target Tcf (ras1G12V;csk/,tcfDN;
Figure 5I). These results indicate that canonical Wg signaling
promotes insulin sensitivity by upregulating inR transcripts.
That is, transformed tissue evaded insulin resistance through a
feed-forward mechanism by which elevatedWg directs elevated
InR (Figure 5K).672 Cell 154, 664–675, August 1, 2013 ª2013 Elsevier Inc.Combinatorial Multinode Drug
Treatments for Diet-Induced Ras/Src
Tumorigenesis
Identifying an HDS-dependent undead
cell phenotype in ras1G12V;csk/ tissue
suggested specific points of therapeutic
intervention: (1) conversion of dietary
sucrose, (2) InR/PI3K metabolic signaling,
(3) canonical Wg/Wnt pathway undead
cell signaling, and (4) Ras plus Src onco-
genic pathways (Figure 5K). Nearly three-
quarters of ras1G12V;csk/ animals raised
on HDS failed to pupariate due to aggres-
sive eye tumors; we utilized pupariation
rate as a quantitative viability assay to
take a stepwise approach toward identi-
fying an optimized whole-animal thera-
peutic cocktail. Time to pupariation was
not affected by drug treatments when
compared to vehicle (DMSO) treatment
alone; pupariation rates were assessedat day 17 AEL, after pupariation curves reached a plateau
(Figure S6A).
Acarbose is an inhibitor of a-glucosidase that is used to treat
type 2 diabetes mellitus (Anderson, 2005). Feeding acarbose in
the presence of HDS led to reduced tumor growth and improved
ras1G12V;csk/ animal survival (Figures 6B and 6J). Pyrvinium, a
small-molecule inhibitor of the canonical Wnt-signaling pathway
(Thorne et al., 2010), suppressed HDS-induced tumor growth at
a concentration that did not affect the growth of wild-type clones
(Figures 6C and S6B); 41.9% of HDS- and pyrvinium-fed animals
achieved pupariation (Figure 6J). We recently developed poly-
pharmacological anticancer compounds (Dar et al., 2012) that
target the Ras, Src, and Tor pathways as single agents. These
represent the central cellular pathways that mediate HDS-
induced tumor growth in ras1G12V;csk/ animals and, indeed,
the compound AD81 suppressed Ras/Src-tumorigenesis and
larval lethality of animals fed HDS (Figures 6D and 6J). Biochem-
ical analysis of dissected eye tissues supported inhibition of Ras,
Src, and Tor pathways by AD81 feeding, though not by the close
analog AD80 (Figure 6I) (Dar et al., 2012). Furthermore, AD81 also
suppressed tumor growth and larval lethality of in-
RCA,ras1G12V;csk/ animals fed a control diet, demonstrating
AD81 can act tumor autonomously (Figure S6C).
Targeting sugar or the Ras, Src, PI3K, or Wg pathways
showed significant but limited efficacy on ras1G12V;csk/ tu-
mors in animals fed HDS. Combining acarbose with pyrvinium,
acarbose with AD81, or pyrvinium with AD81 enhanced survival
to permit 64.4%, 62.9%, and 68.5%, survival of ras1G12V;csk/
animals to pupariation in the presence of HDS, respectively (Fig-
ures 6E–6G and 6J). Strikingly, the triple combination acarbose-
pyrvinium-AD81 achieved a 91.2% rescue level of
ras1G12V;csk/ animals fed HDS (Figures 6H and 6J), far higher
than any single or double drug combination we have tested. We
conclude that targeting multiple nodes in a rational manner may
be required to achieve an optimal therapeutic index, balancing
efficacy with minimal whole-animal toxicity.
DISCUSSION
Epidemiological studies provide strong evidence for an associa-
tion between metabolism-related diseases and cancer, but the
underlying mechanisms that link these two diseases remain
poorly understood. In this study, we demonstrate that dietary su-
crose strongly enhances multiple aspects of Ras/Src-activated
tumors in Drosophila. HDS led to stabilization of tumors within
the epithelium, increased proliferation, and metastasis-like
behavior. Mechanistically, we provide evidence that Ras/Src-
activated cells increase insulin pathway sensitivity in an
otherwise insulin-resistant environment, allowing them to take
advantage of high circulating glucose. The result is a Wg- and
Jnk-dependent enhancement of tumor progression. Our results
support a model in which Ras/Src cells become hypersensitive
to circulating Insulin, leading to efficient activation of insulin/
PI3K signaling (Figure 5K).
A key consequence of increased insulin/PI3K signaling
was the prevention of apoptosis and the promotion of elevated
levels of Wg expression and activity; these two aspects pro-
moted an undead-like cell phenotype that further enhanced
proliferation. We observed low but detectable levels of Wg
expression in ras1G12V;csk/ clones in animals fed a control
diet (Figure 4K); these clones exhibited high levels of apoptosis.
In contrast, Wg accumulated at significantly higher levels in
ras1G12V;csk/ tumors within animals fed HDS (Figure 4L).
High Wg levels led to elevated Diap1 expression and reduced
apoptosis, stabilizing ras1G12V;csk/ clones and revealing
accumulation of Wg within the clone. Our model suggests that
inhibition of cell death in ‘‘HDS tumors’’ is a key aspect of Ras/
Src-mediated transformation and may allow cells to stably and
continuously produce Wg. Wg was expressed within
ras1G12V;csk/ cells in the presence of HDS (Figure 4L and
4M), and phosphorylated Akt levels increased within Ras/Src
clones, but not detectably in nearby wild-type cells (Figure 3I).
Therefore, unlike the conventional undead situation (induced
by Hid plus P35), a Wg-mediated increase in InR expression
and signaling provides a growth advantage specifically within
Ras/Src cells rather than surrounding wild-type tissue. Together,
our data provide evidence that the undead cell phenotype gen-erates an InR-Jnk-Wg-InR feed-forward mechanism that results
in elevated InR expression and a reversal of insulin resistance
(Figure 5K). The result is transformed tissue that is optimized
for insulin-dependent glucose uptake in an animal with hyperin-
sulinemia and hyperglycemia.
The undead phenotype was not fully maintained in secondary
tumors; Dronc expression was lost in distant tumors of
ras1G12V;csk/, though diap1 expression was maintained (Fig-
ures S4G and S4H). These results suggest that secondary
tumors develop progressively distinct properties; understand-
ing these changes will require additional studies. A Chitin-
binding probe suggested progressive steps of tubule maturation
within secondary tumor-associated trachea, including poten-
tially newly expressed Chitin scattered within immature tubules,
tubules filled with solid projections of Chitin, and hollowed out
mature tubules (Figure 2Q). Additional studies will be required
to confirm that this represents neotracheogenesis and, if so,
whether this occurs through processes reminiscent of the
neoangiogenesis that is a common feature of mammalian
metastasis (Bergers and Benjamin, 2003). Strikingly, secondary
tumors expressed high levels of the FGF ortholog Branchless,
an important step in promoting tracheogenesis during develop-
ment (Figure 2R; Sutherland et al., 1996).
The DrosophilaWnt ortholog Wg promotes a tumor’s ability to
evade insulin resistance through its regulation of inR expression
in the presence of HDS feeding, which otherwise promotes dia-
betes-like phenotypes (Figure 5H) (Musselman et al., 2011). High
Wg expression requires both Ras/Src activation and HDS, pro-
moting inR expression through canonical Wg-dTcf signaling (Fig-
ure 5I). These results emphasize a link between canonical Wg
signaling and Insulin signaling. Consistent with this model linking
canonical Wg and Insulin signaling pathways, a recent study re-
ports that reduced expression of skeletal muscle Insulin
receptor, which is linked to hyperinsulinemia and insulin resis-
tance, is enhanced by a mutation in the Wnt coreceptor LRP6 in
humans (Singh et al., 2013).
Tumors with Wnt activation may represent tumor types that
respond and synergize with metabolic defects. Wnt activation
is frequently observed in many tumor types, including those
with a strong association with diabetes, such as hepatocellular
carcinomas and colorectal cancers; activating mutations in
b-catenin and loss-of-function mutations in APC are frequently
found in human hepatocellular carcinoma and colorectal can-
cers (Fodde et al., 2001; Laurent-Puig and Zucman-Rossi,
2006). Incidence of pancreatic cancer has a particularly strong
association with diabetes, suggesting that its constituent muta-
tion load may interface with metabolic dysfunction. Activating
mutations in K-Ras plus upregulation of Src activity are
commonly found in pancreatic ductal adenocarcinoma (PDA)
(Almoguera et al., 1988; Morton et al., 2010), and a mouse K-
Ras/Src pancreatic model developed PDA with shortened la-
tency (Shields et al., 2011).Wnt ligands and transcriptional target
genes of b-catenin are highly expressed in PDA (Pasca di Ma-
gliano et al., 2007), a phenomenon reminiscent of our observa-
tions linking diet, Ras/Src, and Wnt signaling. A clear link has
yet to be established between pancreatic cancers featuring
elevated Ras/Src activity and/or Wnt-pathway activation within
diabetic patients.Cell 154, 664–675, August 1, 2013 ª2013 Elsevier Inc. 673
Our data indicate that limiting dietary sucrose directly or
through blocking its intermediates through compounds such
as acarbose may reduce important aspects of tumor risk and
progression in individuals with metabolism-related diseases.
Combining acarbose with drugs that target the triggering Ras/
Src pathways plus components of the amplification circuit pro-
vided the most robust therapeutic impact on diet-enhanced tu-
mors in our model. These results provide a potential explanation
for how insulin-resistant animals are at increased risk for tumor-
igenesis and emphasize the importance of targeting multiple,
specific nodes to achieve optimal therapeutic value.
EXPERIMENTAL PROCEDURES
Fly Stocks
UAS-ras1G12V, UAS-inRA1325D (inRCA), akt04226, cskj1D8, UAS-tcfDN, UAS-
bskDN, thj5c8 (diap1-lacZ), and UAS-HA-wg flies were obtained from the Bloo-
mington Stock Center. UAS-wgRNAi flies were obtained from the Vienna
Drosophila RNAi Center. The following stocks were kindly provided to us:
FRT82B, cskQ156Stop (by A. O’Reilly and M. Simon), scrib1 (by D. Bilder), and
ey(3.5)-FLP1 (by G. Halder).
To create eyeless-driven GFP-labeled clones, flies with the genotype
ey(3.5)-FLP1; act > y+ > gal4,UAS-GFP; FRT82B, tub-gal80 were crossed
with flies with the following genotypes: (1) UAS-lacZ; FRT82B; (2) UAS-lacZ;
FRT82B, cskQ156Stop/TM6b; (3) UAS-ras1G12V; FRT82B; (4) UAS-ras1G12V;
FRT82B, cskQ156Stop/TM6b; (5) UAS-ras1G12V; FRT82B, cskj1D8/TM6b; (6)
UAS-ras1G12V; FRT82B, scrib1/TM6b; (7) UAS-inRA1325D, UAS-ras1G12V;
FRT82B, cskQ156Stop/TM6b; (8) UAS-ras1G12V; FRT82B, cskQ156Stop, akt04226/
TM6b; (9) UAS-ras1G12V; FRT82B, cskQ156Stop, UAS-wgRNAi/TM6b; (10) UAS-
ras1G12V; FRT82B, cskQ156Stop, UAS-tcfDN/TM6b; (11) UAS-ras1G12V;
FRT82B, cskQ156Stop, UAS-bskDN/TM6b; (12) UAS-inRA1325D, UAS-ras1G12V;
FRT82B, cskQ156Stop, UAS-bskDN/TM6b; (13) UAS-inRA1325D; FRT82B; (14)
FRT82B, UAS-HA-wg; and (15) UAS-ras1G12V; diap1-lacZ, FRT82B,
cskQ156Stop/TM6b; (16) UAS-inrA1325D, UAS-ras1G12V; diap1-lacZ, FRT82B,
cskQ156Stop/TM6b.
Cultures
Cultures were carried out on Bloomington semidefined medium (described by
the Bloomington Stock Center) with modifications. Detailed recipes for the
control diet, HDS, and the high-fat diet have been previously described (Mus-
selman et al., 2011). The following final concentrations of carbohydrates
included 0.15M sucrose (control diet), 1.0M sucrose (HDS), and 2.0M glucose
(high-glucose diet). Cultures were performed at 25C unless otherwise noted.
Immunofluorescence and TUNEL Labeling
Larval eyeswere dissected in PBS, fixed in 4%paraformaldehyde (PFA) in PBS
or PLP-fixative (2.5% PFA, 0.075 M lysine, 0.25% [w/v] Na-periodate in phos-
phate buffer), washed in PBT (PBS containing 0.1% Triton X-100), and incu-
batedwith primary antibodies in PAXDG (PBS containing 1%BSA, 0.3%Triton
X-100, 0.3% deoxycholate, and 5% goat serum), followed by washing and in-
cubation with secondary antibodies in PAXDG. Tissues were counterstained
with TO-PRO-3 (Invitrogen) andmounted in Vectashield mounting media (Vec-
tor Laboratories). Antibodies used were rabbit anti-cleaved caspase-3
(Asp175; Cell Signaling), mouse anti-dMMP1 (Developmental Studies Hybrid-
oma Bank [DSHB]), mouse anti-Wingless (DSHB), mouse anti-b-galactosidase
(DSHB), rabbit anti-Laminin b 1 (Abcam), rabbit anti-phospho-histone H3
(Ser10; Millipore), rabbit anti-Diap1 (a gift from H. Steller), rabbit anti-phos-
pho-Akt (Ser473; Cell Signaling), and rat anti-Branchless (a gift from M. Kras-
now). Secondary Alexa-568-conjugated anti-mouse and anti-rabbit antibodies
were used (Molecular Probes). To label tracheal lumen, Rhodamine-conju-
gated Chitin-binding probe was used (New England Biolabs).
TUNEL was performed using the TMR-Red In Situ Cell Detection Kit (Roche
Diagnostics). Samples were fixed for 15 min in 4% PFA in PBT, washed in PBT
and permeabilized in 100 mM sodium citrate/0.1% Triton X-100 at 65C for
30 min, washed in PBT, and free DNA ends were fluorescein labeled.674 Cell 154, 664–675, August 1, 2013 ª2013 Elsevier Inc.Fluorescent and confocal images were taken with Leica DM5500 micro-
scope equipped with DFC340 FX Monochrome Digital Camera and TSC
SPE confocal microscope.
Drugs
Compounds solubilized in DMSO were diluted directly into the fly medium and
vortexed extensively to obtain homogeneous culture. Drugs used were wort-
mannin and rapamycin (LC Laboratories) and acarbose and pyrvinium pa-
moate (Sigma). AD compoundswere provided by A. Dar andK. Shokat (UCSF).
Western Blotting
Wandering third-instar larvae were rinsed in PBS; the eye discs were dissected
out and placed in Schneider’s Drosophila medium on ice. The eye discs were
incubated with or without 5 mM recombinant human Insulin (Sigma) for 15 min
at room temperature. Eye discs were transferred to amicrocentrifuge tube and
spun down briefly. The supernatant was discarded and the remaining precip-
itates were suspended in SDS sample buffer at a concentration of 10 ml/mg tis-
sue and used to generate western blots. Antibodies used targeted total Akt
(Cell Signaling), phospho-Drosophila Akt (Ser505; Cell Signaling), phospho-
IGF-1 receptor b (Tyr1131)/Insulin receptor b (Tyr1146; Cell Signaling), and
Syntaxin (DSHB). Secondary antibodies were from Cell Signaling.
Glucose Uptake Assay
For the glucose uptake experiments, flies with the genotype ey(3.5) FLP1; act >
y+ > gal4; FRT82B, tub-gal80 were crossed with flies with the following geno-
types: (1) UAS-lacZ; FRT82B; (2) UAS-ras1G12V; FRT82B, cskQ156Stop/TM6b;
(3) UAS-inRA1325D, UAS-ras1G12V; FRT82B, cskQ156Stop/TM6b; and (4) UAS-
ras1G12V; FRT82B, cskQ156Stop, akt04226/TM6b.
Wandering third-instar larvae were rinsed in PBS; the eye discs were
dissected out and placed in Drosophila larval saline (HEPES-NaOH [pH 7.1],
87 mM NaCl, 40 mM KCl, 8 mM CaCl2, 8 mM MgCl2, 50 mM sucrose, and
5 mM trehalose) on ice. The eye discs were incubated with or without 5 mM re-
combinant human Insulin (Sigma) in the presence of 2-(N-(7-nitrobenz-2-oxa-
1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG: Invitrogen) for 15 min at
room temperature. The tissues were washed with Drosophila larval saline
and mounted with a Vectashield (Vector Laboratories).
Quantitative RT-PCR
Total RNA was extracted from the eye discs using the QIAGEN RNeasy Mini
Kit. Oligo-dT primers and Superscript RT-II reverse transcriptase (Invitrogen)
was used to synthesize first-strand DNA. PCR was performed using Power
SYBR Green PCR Master Mix (Applied Biosystems) and analyzed on the
Applied Biosystems StepOnePlus real-time PCR system. Results were
normalized to KinesinmRNA, and RpL32 was used as a control. The following
primers were used: Kinesin-f, 50-GCTGGACTTCGGTCGTAGAG-30; Kinesin-r,
50-CTTTTCATAGCGTCGCTTCC-30; RpL32-f, 50- GCTAAGCTGTCGCACAAA
TG-30; RpL32-r, 50-GTTCGATCCGTAACCGATGT-30; InR-f, 50- ACAAA
ATGTAAAACCTTGCAAATCC-30; InR-r, 50-GCAGGAAGCCCTCGATGA-30;
chico-f, 50-ATCAGGCGATGCGGTC-30; chico-r, 50-ACATAGCGCTCAG
TATCG-30; dLnk-f, 50-GTGTTCGCCTAAAGACAAATGAAAT-30; dLnk-r, 50-
TGTTAGCGTTGTGGGATCCAA-30.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
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